Advanced Filters
noise

respiratory-syncytial-virus-rsv-infection Clinical Trials

A listing of respiratory-syncytial-virus-rsv-infection medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 27 clinical trials
F Francisco Javier González Barcala, Ph.D.

Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control

The main objective is to estimate the annual symptomatic incidence of Bordetella pertussis and RSV infections in patients aged 18 years and over with asthma, which will be identified by PCR, for Bordetella pertussis and by PCR for RSV performed at a specific timepoint from onset of symptoms for each …

18 - 99 years of age Both Phase N/A
T Toru Morikawa, MD, PhD

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)

Study design is multicenter prospective registry study. Participants are consecutive (non-selected, a sequential registration) patients admitted from emergency rooms of participating hospitals who meet the eligibility criteria. The primary objectives are to estimate the prevalence of and risk factors for RS and other respiratory virus infection and their effect on …

50 - 100 years of age Both Phase N/A
R Ricardo Carbajal, MD, PhD

Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis

In July 2023, the Food and Drug Administration approved nirsevimab (Beyfortus®), a long-acting monoclonal antibody, for passive immunization to prevent RSV-associated lower respiratory tract infection (Bronchiolitis) among infants and young children. In Europe, The European Medicines Agency approved the use of BEYFORTUS in October 2022. In France, The Haute Autorité …

1 - 2 years of age Both Phase N/A
J Juan Carlos Rodríguez Díaz, MD

Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection

The primary objective of this clinical performance study is to evaluate and further validate the clinical performance of: ClariLight Influenza A/B & SARS-CoV-2 test kits and ClariLight Influenza A/B & RSV test kits, for the qualitative detection and differential diagnosis of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus …

- 100 years of age Both Phase N/A
N Nicolas De Prost, MD, PhD

Identification and Clinical Validation of Biomarkers Associated With Clinical Severity in Adults Infected With RSV

A short description, 5000 characters Intro: Respiratory Syncytial Virus (RSV) is a frequent, ubiquitous agent of respiratory viral infections. It is the leading viral cause of lower respiratory tract infection (LRTI) in infants and also causes significant morbidity and mortality in adults, especially in the elderly, in patients with cardiorespiratory …

18 - 100 years of age Both Phase N/A

Infant RSV Infections and Health-related Quality of Life of Families

Until today, there is only little information available on how severe RSV infection leading to hospitalisation of the infant impacts the quality of life of affected families. For the ResQ Family project, an online questionnaire will be used to survey parents or caregivers of children up to 24 months currently …

- 100 years of age Both Phase N/A
T Tony Yuan, PhD

SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies

The goal of this observational study is to evaluate new non-invasive passive surveillance technologies, Level 42 AI imPulse™ Una and TOR devices for the detection of COVID-19, Flu, and/or RSV in asymptomatic and symptomatic individuals over age of 18 undergoing COVID-19, Flu, and/or RSV screening and testing at BAMC Ft …

18 - 89 years of age Both Phase N/A

Rewrite in simple language using AI